BACKGROUND Before the introduction of highly active antiretroviral therapy (HAART),
malignancies accounted for less than 10% of all deaths among human immunodeficiency …

Purpose: To describe the clinical features and outcome of HIV-associated primary effusion
lymphoma (PEL) and to compare them with those of the other HIV-associated non-Hodgkin's …

Better response to chemotherapy and prolonged survival in AI... : AIDS Better response to
chemotherapy and prolonged survival in AIDS-related lymphomas responding to highly active …

BACKGROUND The authors sought to determine whether the availability of highly active
antiretroviral therapy (HAART) coincided with changes in the epidemiology of acquired …

Background: AIDS-related lymphoma (ARL) remains a frequent complication of HIV
infection. We analyzed the outcome of patients with ARL with respect to the use and efficacy …

BACKGROUND AND OBJECTIVES: The aim of this study was to assess the feasibility of
high-dose chemotherapy plus autologous hematopoietic stem cell transplantation …

PURPOSE: Non-Hodgkin's lymphoma occurs frequently in patients with human
immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) …

Combined highly active anti‐retroviral therapy (HAART) with protease and reverse
transcriptase inhibitors has modified the natural history of opportunistic infections and …

Abstract Background. High grade non-Hodgkin lymphoma (NHL) remains the most common
Acquired Immune Deficiency Syndrome (AIDS)—associated neoplasia and an important …

Reverse Transcriptase (RT) activity is historically associated with the replication of infectious
retroviruses. Cellular RT-coding genes have subsequently been identified in eukaryotic …